What is the Org number of Rare Thyroid Therapeutics International AB?

Rare Thyroid Therapeutics International AB is registered with Bolagsverket / SCB under Org 5569195109.

What is the revenue of Rare Thyroid Therapeutics International AB?

Rare Thyroid Therapeutics International AB reported revenue of SEK 46,1M in 2024.

Anna Karin Siwertz is Chief Auditor of Rare Thyroid Therapeutics International AB, in role since 2022.

Frank Carl Kennet Rooth chairs the board of Rare Thyroid Therapeutics International AB, in role since 2020.

Rare Thyroid Therapeutics International AB's registered address is Klara Norra Kyrkogata 26.

ABActive

Actively employed in the business

Name	Role	Member since
Current (2)
JE Johan Erik Niclas Bergenmo Chief Auditor	Chief Auditor	2024
MN Mervin Nicklas Mickael Westerholm Chief Executive Officer	Chief Executive Officer	2021
Former (5)
AK Anna Karin Siwertz Chief Auditor	Chief Auditor	2022 – 2022
KJ Kurt Jörgen Lövgren Chief Auditor	Chief Auditor	2021 – 2022
PS Peder Sven Walberg Chief Executive Officer	Chief Executive Officer	2020 – 2021
KL Karl Leonard Daun Chief Auditor	Chief Auditor	2022 – 2024
BC Bo Christer Eriksson Chief Auditor	Chief Auditor	2020 – 2021

Non-executive oversight

Name	Role	Member since
Current (1)
MP Mats Peter Blom	Deputy Board Member	2024
Former (5)
PT Per Thomas Lönngren	Deputy Board Member	2022 – 2024
TO Tomas Olof Leander Gloveus	Board of Directors	2020 – 2021
GM Gudrun Margareta Hörnqvist	Board of Directors	2020 – 2021
PH Per Håkan Albin Åström	Deputy Board Member	2021 – 2022
FC Frank Carl Kennet Rooth	Chairman	2020 – 2021

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Egetis Therapeutics AB (publ)	Company	100%	100%	0001

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.